As part of the continual growth of AHS clinical lab services and review of laboratory space at the University of Alberta Hospital site, both the Clinical Trials and Point of Care Testing (POCT) units will be relocated to the Cross Cancer Institute site.
This will allow Laboratory Services to make room for the Expanded Newborn Metabolic Screening Program at the UAH Site and to strategically move towards consolidation of current services which aligns with our functional programming for Edmonton Hub Lab move.
Read on to see frequently asked questions describing the transition:
All concerns during CT transitional phase can be directed to the following personnel.
Michael Mengel | Edmonton Zone Clinical Department Head
Shelley Rawlake | Executive Director, Edmonton Zone Laboratory Services
Marshall Mulek | Manager, CCI Laboratory / Zone Services
Shannon Austman | Coordinator Special Projects